Concepedia

Impact of Neoadjuvant Chemotherapy in Stage II–III Triple Negative Breast Cancer on Eligibility for Breast-conserving Surgery and Breast Conservation Rates: Surgical Results From CALGB 40603 (Alliance)

Sara Jasinski, Mehra Golshan, David W. Ollila, Constance Cirrincione, Clifford A. Hudis, Eric P. Winer, William M. Sikov, Donald A. Berry, Tracey Weisberg, George Somlo

UNC Libraries · 2020 · 24 citations · 0 references

DOI Full text

Open access

Concepts

MedicineOncologySurgeryBreast OncologyChemotherapySurgical OncologyAdjuvant TherapyBreast Cancer SurgeryBreast SurgeryBreast-conserving TherapyNeoadjuvant ChemotherapyNeoadjuvant TherapyBreast Cancer ChemotherapyNeoadjuvant Chemotherapy IntegrationPost-neoadjuvant TherapyTriple-negative Breast Cancer Therapy

Abstract

To assess the efficacy of neoadjuvant systemic therapy (NST) at increasing the rate of successful breast-conserving therapy (BCT) in triple negative breast cancer.